Year: 2024

ENA Respiratory Announces Peer-Reviewed Publication of First Time in Humans and Influenza Virus Challenge Studies with the Intranasal Innate Immunomodulator INNA-051

When compared to placebo, prophylactic administration of INNA-051 was associated with significantly increased expression of multiple host defense genes and...

Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant

CLR Neurosthenics® launches neurophysiological assessment platform to help prevent sports injuries, optimize performance and improve rehabilitation

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Sports and recreational injuries send more than 3.5 million Americans to the hospital...

BRAIN.ONE Brain Fitness Platform Announces Strategic Partnership with Acclaimed Thought Leader Tim Storey and Global Recovery Advocate Darren Prince

ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership...

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed...

Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023

NORTHAMPTON, MA / ACCESSWIRE / December 17, 2024 / Quest DiagnosticsOriginally published in Quest Diagnostics' 2023 Corporate Responsibility ReportMinimizing our...

error: Content is protected !!